CLINICAL_TRIALS
trial_result
· 2020-03-17
Clinical Trial Update: A Study of A-101 Topical Solution in Subjects With Dermatosis Papulosa Nigra [Phase 2]
Summary
Phase 2 trial of A-101 Topical Solution for Dermatosis Papulosa Nigra completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Aclaris Therapeutics, Inc. | Conditions: Dermatosis Papulosa Nigra | Phase 2 | Status: COMPLETED | Results posted: 2020-03-17